Innoviva (INVA) Operating Leases (2019 - 2026)
Innoviva (INVA) posted Operating Leases of $10.49 million for Q2 2026, up 949.1% from $1 million a year earlier but down 1.8% from the prior quarter.
Powered by 
Analysis
Innoviva (INVA) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Innoviva's Operating Leases came in at $10.87 million, up 821.8% from FY2024.
- Annual Operating Leases shows a three-year compound annual growth rate of 66.0% (FY2022 to FY2025).
- In prior years, Innoviva's Operating Leases was $1.18 million in FY2024 (-27.9%), $1.64 million in FY2023 (-31.2%) and $2.38 million in FY2022.
- Quarterly Operating Leases has run from a low of $905,000 in Q3 2025 to a high of $10.87 million in Q4 2025 over five years.
- On a year-over-year basis, Operating Leases has increased in each of the last three quarters, with growth averaging 359.1% over the last seven quarters.
- The strongest year-over-year quarter for Operating Leases in the past five years was Q2 2026, with growth of 949.1%; the weakest was Q2 2025, with a decline of 49.6%.
- According to Business Quant data, Operating Leases for the three prior quarters was $10.68 million (Q1 2026), $10.87 million (Q4 2025) and $905,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Innoviva | 1.54 Bn | -748.67 Mn | 90.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.49 Mn |
| Mar 31, 2026 | 10.68 Mn |
| Dec 31, 2025 | 10.87 Mn |
| Sep 30, 2025 | 905,000.00 |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | 1.09 Mn |
| Dec 31, 2024 | 1.18 Mn |
| Sep 30, 2024 | 1.59 Mn |
| Jun 30, 2024 | 1.98 Mn |
| Mar 31, 2024 | 1.30 Mn |
| Dec 31, 2023 | 1.64 Mn |
| Sep 30, 2023 | 1.95 Mn |
| Jun 30, 2023 | 1.86 Mn |
| Mar 31, 2023 | 2.10 Mn |
| Dec 31, 2022 | 2.38 Mn |
| Sep 30, 2022 | 2.70 Mn |
| Jun 30, 2022 | 3.09 Mn |
| Mar 31, 2022 | 3.30 Mn |
| Jun 30, 2019 | 1.16 Mn |
| Mar 31, 2019 | 1.24 Mn |
API Access
Innoviva Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=INVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "INVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=INVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();